Medically reviewed by Doru Paul, MD CD20 is a CD marker—a molecule on the cell surface that can be used to identify and type ...

GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB-205), a novel CD5 CAR-NK cell therapy. This "first ...